CD19 and B-cell chronic lymphocytic leukemia: However, glycomic studies in the field of CLL research are limited, though Chen et al. [132] found a 2-fold difference in the GlcNAc-6-0-sulfated α2-6-sialyl LacNAc between CLL cells and healthy CD19+ lymphocytes [132].